FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2958896778> ?p ?o ?g. }

• W2958896778 endingPage "R118" @default.
• W2958896778 startingPage "R107" @default.
• W2958896778 abstract "In recent years, the development of immunotherapy has constituted a revolution in the therapy for many cancers, with a specific toxicity profile including endocrine immune-related adverse events. Immune check point inhibitors (ICI)-induced hypophysitis is a common endocrine side effect, particularly with CTLA-4 antibodies and combination therapy, with frequent hormonal deficiencies at diagnosis. It can be difficult to evoke such diagnosis as the initial clinical symptoms are not specific (headache, asthenia…); thus, patients receiving such immunomodulatory therapies should be closely monitored by systematic hormone measurements, especially in the first weeks of treatment. Usually, hormonal deficiencies improve, except for corticotroph function. Despite a lack of large prospective studies on ICI-induced hypophysitis, some detailed longitudinal cohort studies have focused on such cases of hypophysitis and allow for optimal monitoring, follow-up and management of patients with this immune-related adverse event. In the case of ICI-induced hypophysitis, patients need long-term multidisciplinary follow-up, with specific education for those patients with corticotropin deficiency to allow them to be autonomous with their treatment. In this review, based on a clinical case, we detail the most relevant and novel aspects related to the incidence, diagnosis, treatment, evolution and management of hypophysitis induced by immunotherapy, with a focus on possible mechanisms and current recommendations and guidelines. Lastly, we emphasize several key points, such as the absence of indication to systematically treat with high-dose glucocorticoid and the pursuit of immunotherapy in such hypophysitis. These points should be kept in mind by oncologists and endocrinologists who treat and monitor patients treated by immunotherapy." @default.
• W2958896778 created "2019-07-23" @default.
• W2958896778 creator A5074308093 @default.
• W2958896778 creator A5077018348 @default.
• W2958896778 creator A5080938537 @default.
• W2958896778 date "2019-09-01" @default.
• W2958896778 modified "2023-10-14" @default.
• W2958896778 title "MANAGEMENT OF ENDOCRINE DISEASE: Immune check point inhibitors-induced hypophysitis" @default.
• W2958896778 cites W1185432402 @default.
• W2958896778 cites W1536480181 @default.
• W2958896778 cites W1605630196 @default.
• W2958896778 cites W1968805929 @default.
• W2958896778 cites W1991656907 @default.
• W2958896778 cites W2002673340 @default.
• W2958896778 cites W2036109307 @default.
• W2958896778 cites W2036195858 @default.
• W2958896778 cites W2056085563 @default.
• W2958896778 cites W2066671159 @default.
• W2958896778 cites W2068611826 @default.
• W2958896778 cites W2068946981 @default.
• W2958896778 cites W2076067786 @default.
• W2958896778 cites W2085172491 @default.
• W2958896778 cites W2097560051 @default.
• W2958896778 cites W2103741075 @default.
• W2958896778 cites W2112196468 @default.
• W2958896778 cites W2113287405 @default.
• W2958896778 cites W2145853100 @default.
• W2958896778 cites W2151507811 @default.
• W2958896778 cites W2152707359 @default.
• W2958896778 cites W2158719475 @default.
• W2958896778 cites W2166107256 @default.
• W2958896778 cites W2169656611 @default.
• W2958896778 cites W2193279488 @default.
• W2958896778 cites W2277326116 @default.
• W2958896778 cites W2289841322 @default.
• W2958896778 cites W2519279652 @default.
• W2958896778 cites W2529373149 @default.
• W2958896778 cites W2533633657 @default.
• W2958896778 cites W2586675028 @default.
• W2958896778 cites W2635292439 @default.
• W2958896778 cites W2769908638 @default.
• W2958896778 cites W2773212848 @default.
• W2958896778 cites W2791604689 @default.
• W2958896778 cites W2868973925 @default.
• W2958896778 cites W2884583918 @default.
• W2958896778 cites W2887469571 @default.
• W2958896778 cites W2891536507 @default.
• W2958896778 cites W2915107617 @default.
• W2958896778 doi "https://doi.org/10.1530/eje-19-0169" @default.
• W2958896778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31311002" @default.
• W2958896778 hasPublicationYear "2019" @default.
• W2958896778 type Work @default.
• W2958896778 sameAs 2958896778 @default.
• W2958896778 citedByCount "66" @default.
• W2958896778 countsByYear W29588967782019 @default.
• W2958896778 countsByYear W29588967782020 @default.
• W2958896778 countsByYear W29588967782021 @default.
• W2958896778 countsByYear W29588967782022 @default.
• W2958896778 countsByYear W29588967782023 @default.
• W2958896778 crossrefType "journal-article" @default.
• W2958896778 hasAuthorship W2958896778A5074308093 @default.
• W2958896778 hasAuthorship W2958896778A5077018348 @default.
• W2958896778 hasAuthorship W2958896778A5080938537 @default.
• W2958896778 hasBestOaLocation W29588967781 @default.
• W2958896778 hasConcept C126322002 @default.
• W2958896778 hasConcept C177713679 @default.
• W2958896778 hasConcept C187212893 @default.
• W2958896778 hasConcept C197934379 @default.
• W2958896778 hasConcept C203014093 @default.
• W2958896778 hasConcept C203092338 @default.
• W2958896778 hasConcept C2777658017 @default.
• W2958896778 hasConcept C2777701055 @default.
• W2958896778 hasConcept C2778491484 @default.
• W2958896778 hasConcept C2779134260 @default.
• W2958896778 hasConcept C2780194577 @default.
• W2958896778 hasConcept C46699223 @default.
• W2958896778 hasConcept C535046627 @default.
• W2958896778 hasConcept C71315377 @default.
• W2958896778 hasConcept C71924100 @default.
• W2958896778 hasConcept C8891405 @default.
• W2958896778 hasConceptScore W2958896778C126322002 @default.
• W2958896778 hasConceptScore W2958896778C177713679 @default.
• W2958896778 hasConceptScore W2958896778C187212893 @default.
• W2958896778 hasConceptScore W2958896778C197934379 @default.
• W2958896778 hasConceptScore W2958896778C203014093 @default.
• W2958896778 hasConceptScore W2958896778C203092338 @default.
• W2958896778 hasConceptScore W2958896778C2777658017 @default.
• W2958896778 hasConceptScore W2958896778C2777701055 @default.
• W2958896778 hasConceptScore W2958896778C2778491484 @default.
• W2958896778 hasConceptScore W2958896778C2779134260 @default.
• W2958896778 hasConceptScore W2958896778C2780194577 @default.
• W2958896778 hasConceptScore W2958896778C46699223 @default.
• W2958896778 hasConceptScore W2958896778C535046627 @default.
• W2958896778 hasConceptScore W2958896778C71315377 @default.
• W2958896778 hasConceptScore W2958896778C71924100 @default.
• W2958896778 hasConceptScore W2958896778C8891405 @default.
• W2958896778 hasIssue "3" @default.
• W2958896778 hasLocation W29588967781 @default.

• next